Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
With a market cap of 8.67B, Alkermes(ALKS) trades at $51.98. The stock has a price-to-earnings ratio of 57.37.
On 2026-07-15, Alkermes(ALKS) stock moved within a range of $50.49 to $52.20. With shares now at $51.98, the stock is trading +3.0% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 1.53M, compared to an average daily volume of 1.67M.
Over the past 52 weeks, Alkermes(ALKS) stock has traded between a high of $55.67 and a low of $25.17.
Over the past 52 weeks, Alkermes(ALKS) stock has traded between a high of $55.67 and a low of $25.17.
ALKS News
...
Alkermes (ALKS) announced results from a planned interim analysis of the ongoing long-term extension, LTE, study evaluating alixorexton in adults with narcoleps...
Advertisement What Alkermes’ Russell 2000 Dynamic Index Addition Signals for Investors Alkermes (NasdaqGS:ALKS) was added to the Russell 2000 Dynamic Index on...
Analyst ratings
76%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.